Physicians' Academy for Cardiovascular Education

The role of pioglitazone in the treatment of Type 2 diabetes: Update 2016

Lecture - Nov. 6, 2016 - Seoul, Korea - Prof. Guntram Schernthaner, MD Vienna, Austria - CDMC 2016, Seoul

This lecture was part of a Cardio Diabetes Master Class 'Contemporary issues in T2DM & cardiovascular risk: Review of latest insights for optimizing patient management' held on November 5-6 2016 in Seoul Korea

Educational information

The educational objectives of this Cardio Diabetes Master Class were:

CME accreditation

The Cardio Diabetes Master Class was accredited by the European Board for Accreditation in Cardiology (EBAC) for 9 CME credit hours


Prof. Guntram Schernthaner, MD is Professor of Medicine Rudolfstiftung Hospital Vienna, Department of Medicine I, Vienna, Austria


The master class is supported by an unrestricted educational grant provided by Takeda Pharmaceuticals

View slides of this presentation

The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: